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Objective: To investigate the mechanisms by which chronic tobacco smoking promotes intervertebral disc
degeneration (IDD) and vertebral degeneration in mice.
Methods: Three month old C57BL/6 mice were exposed to tobacco smoke by direct inhalation (4 ciga-
rettes/day, 5 days/week for 6 months) to model long-term smoking in humans. Total disc proteoglycan
(PG) content [1,9-dimethylmethylene blue (DMMB) assay], aggrecan proteolysis (immunobloting anal-
ysis), and cellular senescence (p16INK4a immunohistochemistry) were analyzed. PG and collagen
syntheses (35S-sulfate and 3H-proline incorporation, respectively) were measured using disc organotypic
culture. Vertebral osteoporosity was measured by micro-computed tomography.
Results: Disc PG content of smoke-exposed mice was 63% of unexposed control, while new PG and
collagen syntheses were 59% and 41% of those of untreated mice, respectively. Exposure to tobacco
smoke dramatically increased metalloproteinase-mediated proteolysis of disc aggrecan within its
interglobular domain (IGD). Cellular senescence was elevated two-fold in discs of smoke-exposed mice.
Smoke exposure increased vertebral endplate porosity, which closely correlates with IDD in humans.
Conclusions: These ﬁndings further support tobacco smoke as a contributor to spinal degeneration.
Furthermore, the data provide a novel mechanistic insight, indicating that smoking-induced IDD is a result
of both reduced PG synthesis and increased degradation of a key disc extracellular matrix protein, aggrecan.
Cleavage of aggrecan IGD is extremely detrimental as this results in the loss of the entire
glycosaminoglycan-attachment region of aggrecan, which is vital for attracting water necessary to coun-
teract compressive forces. Our results suggest identiﬁcation and inhibition of speciﬁc metalloproteinases
responsible for smoke-induced aggrecanolysis as a potential therapeutic strategy to treat IDD.
Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.Introduction
Intervertebral disc degeneration (IDD) is responsible for many
spine-related disorders, including back pain, that cause both
temporary and permanent disabilities in a signiﬁcant fraction ofN. Vo, Department of Ortho-
43, University of Pittsburgh
1-412-648-1092; Fax: 1-412-
. Kang, Department of Ortho-
niversity of Pittsburgh School
-1090; Fax: 1-412-383-5307.
@upmc.edu (N. Vo).
r Ltd on behalf of Osteoarthritis Reworkers, aged 18e641,2. Back pain is the second most common
reason for a doctor’s visit among Americans today3. Tobacco smoking
is associated with spine-related pain. A prospective study of the
Icelandic population documented higher frequency of back pain and
disc degeneration in smokers than nonsmokers4. Likewise a longi-
tudinal study of 5180 Finnish forest industry workers revealed
smoking as a key contributing factor to radiating neck pain and
sciatic pain5. Heavy smokers who are overweight or repeatedly
perform hard physical labor were also reported to have signiﬁcantly
higher frequency of lower back pain6. Tobacco smoking has enor-
mous negative health and economic impact, including a strong
correlation with back pain and degenerative spinal disorders.
Nevertheless, over 1.1 billion people worldwide continue to smoke7.search Society International.
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a causal factor in IDD. An 11-year follow-up study of nearly 60,000
adolescents reported tobacco smoking as a major risk factor for
lumbar discectomy8. Smoking was also a positive predictor of
hospitalization for back disorders in a cohort study of 902 metal
industry employees9. Other studies indicate that smoking exacer-
bates pre-existing IDD and signiﬁcantly delays recovery from spinal
surgery10. Battie and coworkers reported about 20% greater disc
degeneration via magnetic resonance imaging (MRI) in smokers
compared to nonsmoking identical twins in whom genetic and
other environmental differences were accounted for11.
Despite this strong correlative evidence, the mechanism by which
tobacco smoke promotes IDD is not known. Intervertebral discs (IVDs)
of rats exposed to passive tobacco smoke for 8 weeks exhibited
decreased collagen expression, increased interleukin (IL)-1b expres-
sion and annular disorganization12. Early work by Holm and
Nachemsononporcinemodels suggests that tobacco smoking induces
vasoconstriction and thereby reduces the nutrient uptake within the
disc, leading to IDD13. This idea was supported by subsequent studies
on rabbits treated with nicotine, a major tobacco smoke constituent
responsible for addiction and vasoconstriction14. This study showed
decreased density of vascular buds and narrowing of the vascular
lumen in the vicinity of the vertebral endplate in response to smoke
exposure. These observations led to the current theory which posits
that tobacco smoke causes disc degeneration indirectly through
nicotine-induced vasoconstriction, resulting in decreasednutrient and
waste exchange between discs and the surrounding vascular system.
Herein, we investigated the mechanism of smoking-related
spinal degeneration by exposing mice to tobacco smoke inhala-
tion for 6 months to mimic chronic heavy smoking in humans.
Exposed mice in this direct inhalation model exhibited severe loss
of vertebral bone and loss of disc matrix proteoglycan (PG), a well-
established hallmark of IDD. This chronic tobacco smoking expo-
sure induced matrix metalloproteinase (MMP)- and a disintegrin
and metalloproteinase with thrombospondin motifs (ADAMTS)-
mediated proteolysis of disc aggrecan interglobular domain (IGD),
which is particularly pathological due to the resulting loss of the
entire glycosaminoglycan (GAG) attachment region from the PG
aggregate, revealing a novel molecular mechanism for IDD.
Method
Exposure to tobacco smoke
Three-month-old C57BL/6 mice (n¼ 25) were exposed to tobacco
smoke by direct inhalation (4 unﬁltered cigarettes/day 5 days/
week for 6 months) using a smoking apparatus as previously
described15. University of Kentucky 3R4F research referenced ciga-
rettes were used in this study. The animals tolerated the treatment
without evidence of toxicity (carboxyhemoglobin levels <10%).
Unexposed age- and sex- matched littermates (n¼ 20) kept in the
same facility environment were used as controls.
Isolation of nucleus pulposus (NP), annulus ﬁbrosus, and whole
mouse intervertebral discs
The experiments involving mice were approved by the Univer-
sity of Pittsburgh Institutional Animal Care and Use Committee.
Isolation of mouse spines and intervertebral disc tissue were done
as described previously16.
Histological staining
Isolated spines were decalciﬁed and embedded in parafﬁn
(Tissue Tek processor and Leica embedder). Seven-micrometersections were stained with either hematoxylin and eosin (H&E) or
safranin O and fast green dyes (Fisher Scientiﬁc) by standard
procedures and photographed under 40-200 magniﬁcation
(Nikon Eclipse Ts100).1,9-dimethylmethylene blue (DMMB) colorimetric assay for sulfated
GAGs
Nucleus pulposus (NP) and annulus ﬁbrosus (AF) tissue were
isolated from six lumbar IVDs of each mouse, pooled and digested
using papain at 60C for 2 h. GAG content was measured in dupli-
cate by the DMMB procedure17 using chondroitin-6-sulfate (Sigma
C-8529) as a standard. The DNA concentration of each sample was
measured using the PicoGreen assay (Molecular Probes) and used to
normalize the GAG values.Quantitation of matrix synthesis
Disc organ cultures of isolated functional spine units (FSU), each
consisting of vertebra-disc-vertebra, were established as previously
described18. PG synthesiswasmeasured by 35-S-sulfate incorporation
and collagen synthesis was determined from collagenase-sensitive
3-H-proline incorporation, both as described previously19. The rate
of PG and collagen synthesiswas calculated as the fmoles of sulfate or
3-H-proline incorporated per mg DNA.Western analysis
Entire lumbar discs were removed en bloc by creating an incision
along the endplates/vertebral bone interface. Five to ten discs from
each mouse were used to extract proteins at 4C under continuous
agitation for 48 h, using 30 volumes (volume to weight of disc
tissue) of 4 M guanidinium chloride, 50 mmol/L sodium acetate, pH
5.8, 10 mmol/L ethylenediamminetetraacetate (EDTA), and
COMPLEAT proteinase inhibitor cocktail (Roche). Aliquots of disc
extracts (100 mL) were precipitated with 9 volumes of ethanol and
recovered by centrifugation. Pellets were washed twice in 75%
ethanol, lyophilized and redissolved in 100 mL, 50 mM sodium
acetate (pH 6.0), then digested overnight with 1 mU keratinase II.
The solution was then adjusted to 100 mM Tris, 100 mM sodium
acetate (pH 7.3), and digested for 6 h with 10 mU chondroitinase
ABC. Digested protein extract were resolved on a sodium dodecyl
sulfate (SDS)/polyacrylamide gel electrophoresis (PAGE) (4e12%
gradient gel, Invitrogen). To control for loading, the same amount
of tissue wet weight (1 mg) was loaded per well, i.e., 33 mL of the
100 mL contained the protein extracted from 3 mg tissue was used
for SDS/PAGE. Samples were analyzed by immunoblot as previously
described20 using antibodies (1:1000 dilution 1 Ab, 1:5000 dilu-
tion 2 Ab) raised against the ADAMTS-generated neoepitope
NITEGE (Ab1320)21 and MMP-generated neoepitope VDIPEN
(Ab1319)22. The anti-NITEGE neoepitope antibody cross-reacts with
the NVTEGE neoepitope generated from mouse aggrecan.Immunohistochemistry
Parafﬁn embedded sections were used to probe for ADAMTS-
generated neoepitope NVTEGE and MMP-generated neoepitope
VDIPEN using the same antibodies as in Western analysis (1:750
dilution of Ab1319 and 1:250 dilution of Ab1320). The immuno-
histochemical procedure was performed as described23. Forty-two
day-old rat tibial growth plate was used as a positive control for
anti-VDIPEN and anti-NITEGE detection. A negative control without
addition of the primary antibodies was also performed.
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Frozen sections of discs were treated with the TUNEL reagents
(Roche) to detect apoptotic cells as previously described by the
manufacturer and counterstained with the Hoechst nuclear stain to
detect total cells in the specimens. Immunohistochemistry was
used to localize the senescence marker P16INK4a in disc tissue
using a procedure previously described24. At least three random
ﬁelds in three sections from each tissue sample were imaged at
200 to quantify the percent P16INK4a- and TUNEL-positive cells.
Average values from nine ﬁelds (3 ﬁeld/NP 3 mice) were calcu-
lated with 95% conﬁdence intervals.
Micro-computed tomography (m-CT)
m-CT scans of the spines isolated from mice were acquired using
a VivaCT 40 (Scanco Medical) with 15 mm isotropic voxel size
resolution, 70 kVp of energy and 114 mA of current. After the
acquisition of transverse two-dimensional image slices, three-
dimensional (3D) reconstruction of the lumbar vertebrae was
performed using a constant threshold value which was selected
manually for the bone voxels by visually matching the threshold
areas to the gray-scale images. Trabecular bone was evaluated in
the region approximately 150 slices below the cranial and above
the caudal growth plates, as described25. Brieﬂy, the anatomic
region of interest was selected by manually drawing contours on
each slice thenmerging them together. Trabecular bone parameters
were assessed using Scanco evaluation software provided by the
manufacturer, which calculates bone volume fraction (bone volume
BV/total volume TV). Porosity was calculated using the formula 1-
BV/TV. The porosity of proximal and distal endplates of L3eL5
vertebrae was calculated similarly by drawing contours on axial
slices.
Statistical analysis
Values represent the average of 6e9 trials from different mice
with 95% conﬁdence intervals calculated to determine statistical
signiﬁcance at P¼ 0.05. The conﬁdence intervals were calculated
based on the t-distribution because of the small sample size.
Results
Exposure to tobaccos smoke
The goal of this study was to investigate the effects of long-term
tobacco smoking on extracellular matrix PG homeostasis in inter-
vertebral discs. For this we exposed three-month-old mice to
tobacco smoke by direct inhalation (4 cigarettes/day 5 days/week
for 6 months) to model chronic ﬁrst-hand smoking in humans. This
regiment was chosen for several reasons. At 3 months of age mice
begin to reach skeletal maturity, and initiation of smoke exposure
at this age mimics young human adults when they most likely
begin to smoke. Exposure to ﬁve unﬁltered cigarettes per day in
mice correspond to a smoking regimen of more than one pack per
day in humans26,27, and 6 months of smoke exposure induces the
development of pulmonary emphysema which models chronic
smoking in humans (equivalent of 15e20 years)26. Under these
conditions, carbon monoxide does not reach toxic levels (peak CO-
Hbw 10%), and the mice appear grossly normal (without weight
loss). We have examined the effects of smoking on discs of mice
after 2 months of exposure, which also exhibited IDD features,
albeit to a much lesser extent than those observed in mice exposed
to smoke for 6 months. We chose to report the results obtained
from the 6 months exposure regimen in this study.Mice exposed to tobacco smoke displayed loss of matrix PG in their
intervertebral discs
Mice chronically exposed to tobacco smoke showed loss of
cellularity in the endplate and dramatic loss of matrix PG in the
intervertebral discs (Fig. 1). Safranin O staining of sulfated PGs
revealed a substantial reduction of PGs in the discs of smokers
compared to those from nonsmoking controls [Fig. 1(A)]. This was
conﬁrmed by the quantitative DMMB assay measuring sulfated
GAGs [Fig. 1(B)]. The GAG content of exposed mice (329100 mg
GAG/ng DNA in NP and 6013 mg GAG/ng DNA in AF) was much
reduced compared to unexposed mice (516 79 mg GAG/ng DNA in
NP and 88 34 mg GAG/ng DNA in AF). Compared to AF tissue, NP
PG was reduced to a much greater extent by tobacco smoking. This
is perhaps due to differential response of tissue to smoke-induced
stress.Chronic tobacco smoke exposure reduced disc matrix protein
synthesis
Net loss of disc PGs could be caused by decreased PG synthesis
and/or increased PG degradation. We determined PG synthesis by
measuring the level of 35S-sulfate incorporated into the discs of
mice ex vivo after chronically exposing the mice to cigarette smoke.
Exposed mice had 112 fmoles sulfate/ng DNA, a 35% reduction
compared to that of unexposed control (174 fmoles sulfate/ng
DNA) [Fig. 2(A)]. In addition, the discs of exposedmice incorporated
2.5 fold less collagenase-sensitive 3-H-proline than unexposedmice
(0.17 0.03 fmoles proline/ng DNA in smokers vs 0.410.12 fmoles
proline/ng DNA in nonsmokers), suggesting that new collagen
synthesis was also compromised in discs of mice exposed to
tobacco smoke [Fig. 2(B)].Chronic exposure to cigarette smoke increased proteolytic cleavage
of aggrecan in discs
To determine if PG breakdown also contributed to PG loss in
smoke-exposed mice, we performed immunoblot analysis using
antibodies against the VDIPEN and NITEGE neo-epitopes of aggre-
can21,22 to detect proteolytic cleavage of the IGD of aggrecan, the
primary PG constituent responsible for the osmotic turgidity of the
disc [Fig. 3(A)]. The ADAMTS-generated aggrecan G1 fragments
terminating in NVTEGE-392 were detected in the discs of smoke-
exposed mice, but not unexposed control mice [Fig. 3(B), lanes
2e3]. Similarly, the MMP-generated aggrecan G1 fragment termi-
nating in VDIPEN-360 was detected at higher levels (wtwo-fold by
densitometry) in smoke-exposed mice compared to unexposed
[Fig. 3(B), lanes 4e5]. Similar results were observed when anti-G1
antibodies were used to probe these aggrecan proteolytic frag-
ments [Fig. 3(B), lanes 6e7]. The immunoblot data were further
conﬁrmed by immunohistochemistry, where aggrecan fragments
containing the NVTEGE-392 and VDIPEN-360 neo-epitopes were
detected at higher levels in discs of smoke-exposed mice compared
to unexposed controls [Fig. 3(C)].
It should be noted that the same amount of tissue wet weight
(1 mg) was loaded per well in our immunoblotting analysis. Tissue
wet weight is typically used for loading normalization for analysis
of aggrecan fragments in intervertebral disc tissue because no
known matrix protein in the extracellular matrix of disc tissue that
exists in abundant and constant quantity that could be used as
loading control, unlike a loading control such as actin for analysis of
cellular protein. We did not use total GAG or total protein extract
from disc tissue as loading control as either of these constituents
can be variable in discs of treated and untreated mice.
Fig. 1. Chronic tobacco smoke exposure decreased disc matrix PG. (A) Representative images of H&E (left panel, bar¼ 250 mm) and Safranin O/fast green stained discs (right
panel, bar¼ 50 mm). Decreased cellularity in AF (yellow arrows) and endplate (black arrows) in H&E stained discs are indicated. Decreased safranin O staining of PG (red stain) in the
NP was observed in smoke-exposed mice compared to unexposed mice (black arrow). (B) DMMB assay for total GAG content from AF and NP tissue of smoke-exposed mice and
untreated controls. NS¼ nonsmokers, S¼ smokers. Average values from seven exposed mice and seven unexposed controls are shown with 95% conﬁdence interval.
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senescence in their intervertebral discs
The most obvious cause of reduced PG synthesis is if functional
cells are lost. Hence we measured apoptotic cells by TUNEL assay
and senescent cells by immunodetection of a cellular senescence
marker, P16INK4a. More p16-positive cells (27 7%) were detected
in discs of mice exposed to smoke compared to unexposed controls
(147%), indicating increased cellular senescence in discs ofFig. 2. Chronic exposure to tobacco smoke decreased newmatrix protein synthesis
in intervertebral disc. PG synthesis as measured by 35S-sulfate incorporation (A) and
collagen synthesis by collagenase-sensitive incorporation of 3-H-proline (B) in inter-
vertebral discs of mice exposed to tobacco smoking (S) and non-exposed control (NS).
Average values from seven exposed mice and seven unexposed controls are shown
with 95% conﬁdence interval.smokers (Fig. 4). There was no detectable difference in the percent
of apoptotic cells (0.6e0.7%) between the two groups of mice
(Fig. 4).
Smoking-induced vertebral bone loss
Degenerative changes in the disc highly correlate with the
degenerative changes in its surrounding tissue, including the
vertebral endplate and the vertebral bodies28. Recent m-CT analysis
of human lumbar region revealed that the vertebral endplate
becomes progressively porous and that the trabecular thickness
(Tb.T) decreases with disc aging and advancing disc degeneration28.
To determine if these changes also occur in our tobacco smoke-
exposed mice, we utilized m-CT to analyze the bone microstructure
of the vertebral endplates and vertebral bodies. Mice exposed to
tobacco smoke also showed degenerative changes in their verte-
brae as assessed by m-CT. These include increased bone porosity and
signiﬁcantly reduced trabecular bone thickness (Fig. 5). Vertebral
bone porosity of exposed mice was 0.730 0.012 compared to
0.698 0.036 for unexposed controls. Trabecular bone thickness
decreased from 0.078 0.003 mm in nonsmokers to 0.072 0.001
mm in smokers. Total trabecular BV also decreased (3.2 0.05 mm3
in smokers vs 3.4 0.07 mm3 in nonsmokers). Porosity also
increased signiﬁcantly within the endplate region, with an average
value of 0.36 0.03 observed for smokers compared to 0.18 0.03
for nonsmokers.
Discussion
Previous studies link tobacco smoking to disc degeneration,
spinal disorders and lower back pain, but most of them are correl-
ative and do not necessarily establish a direct causeeeffect rela-
tionship between smoking and IDD. The objective of this study was
to determine if chronic ﬁrst-hand exposure to cigarette smoke
Fig. 3. Chronic cigarette smoke exposure increased disc aggrecan proteolysis. (A) Schematic representation of mouse PG aggregate consisting of the core aggrecan protein bound
to hyaluronan via a linker protein. The MMP-mediated cleavage site (yielding VDIPEN neo-epitope) and ADAMTS-mediated cleavage site (yielding NVTEGE neo-epitope) within the
IGD residing between the G1 and G2 domain of aggrecan are indicated. (B) Immunoblot analysis of G1 fragments bearing the NVTEGE and VDIPEN neo-epitopes. Protein size marker
(M), nonsmokers (N), smokers (S). To control for loading, proteins extracted from 1 mg of disc tissue wet weight were loaded per well. The anti-NITEGE neoepitope antibody cross-
reacts with the NVTEGE neoepitope generated from mouse aggrecan. (C) Immunohistochemical detection of aggrecan fragments using antibodies raised against the NITEGE and
VDIPEN neo-epitopes. Forty-two day-old rat tibial growth plate was used as a positive control for anti-VDIPEN (C.1) and anti-NITEGE (C.2) detection. A negative control without
addition of the primary antibodies is shown in C.3. Arrow indicates sites of detection of positive signal. The bars represent 100 mm.
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discs.We demonstrated unambiguously that long-term exposure of
healthy adult mice to tobacco smoke signiﬁcantly depletes disc
matrix PG content, a well-established hallmark of IDD. PG synthesis
was decreased and PG degradation increased, providing novel
insight into themechanism of PG loss as a consequence of smoking.
Discs of exposed mice exhibited increased MMP- and ADAMTS-
mediated proteolysis of the aggrecan IGD. Cleavagewithin the IGD is
considered most pathological because it leads to loss of the entire
GAG-containing region that is vital for disc function29. We also
demonstrated that chronic exposure to smoke leads to vertebral
bone loss, which is consistent with results recently reported insmoke-exposed rats30. These results are summarized in Fig. 6. Our
studies provide deﬁnitive experimental evidence that tobacco
smoke negatively impacts the overall spine health.
Disc degenerative features in smoke-exposed mice in this study
generally matched those observed in human IDD. In this study,
smoke-exposed mice exhibited a greater percentage of cells
expressing the cellular senescence marker, P16INK4a, in their discs,
consistent with the reported ﬁnding of accelerated cellular senes-
cence as a correlative factor of disc degeneration in humans31.
Decreased matrix PGs and collagens have been reported in human
disc degeneration32, and these features were also observed in discs
of mice exposed to tobacco smoke in our study. Furthermore, we
Fig. 4. Effects of exposure to tobacco smoking on cell senescence and cell death in mouse intervertebral discs. (A), Left panel, immunohistochemical detection of P16INK4a,
a cellular senescence marker, to distinguish senescent (brown, arrow) from non-senescent (blue) cells in NP tissue. Right panel, TUNEL assay to identify apoptotic cells (green) in
disc AF tissue. Insets, nuclear DAPI stain to reveal tissue cellularity. The bars represent 20 mm. (B) Quantitative assessment of the percent immunopositive cells for P16INK4a and
TUNEL. Average values from seven random ﬁelds are shown with 95% conﬁdence interval.
D. Wang et al. / Osteoarthritis and Cartilage 20 (2012) 896e905 901demonstrated that long-term exposure to tobacco smoke in mice
resulted in increased disc aggrecan proteolysis, a well-established
hallmark of human disc aging and disc degeneration33,34. Degen-
erative changes in the other structural components of the spines
were also observed in smoke-exposed mice. These included
increased porosity of the vertebral endplate and vertebral body and
decreased vertebral Tb.T, which highly correlate with disc aging
and advancing disc degeneration in humans28. Careful quantitative
analysis of human spine specimens by Rodriguez and coworkers28
recently showed that vertebral endplate porosity increased withadvancing disc aging and degeneration, and this inversely corre-
lates with disc PG content. Our study also showed that the endplate
became more porous with tobacco smoking and this correlates
with the degenerative changes in the intervertebral disc. It is still
not known how increased endplate porosity affects the number
and/or quality of vertebral capillaries and how this in turn inﬂu-
ences nutrient/waste exchange between the disc and endplate
tissue. These questions await further studies.
Smoking-induced aggrecan proteolysis (Fig. 3) is a novel and
important ﬁnding. Until now smoke-induced cleavage within the
Fig. 5. Smoking exposure effects on vertebral bone. (A) Representative 3D reconstruction of the micro-computed tomographical images of the spine (top) and vertebral trabecular
bone (bottom). All panels are at the same magniﬁcation and the bar represents 500 mm. (B) Smoking-induced changes in Tb.T, vertebral bone porosity, and vertebral endplate
porosity. Quantitative bone parameters (TV, BV, Tb.T). Average values from seven exposed mice and seven unexposed controls are shown with 95% conﬁdence interval.
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models or tissue types after cigarette smoke exposure, including
articular cartilage and lung, which contain abundant matrix PGs.
The proteolytic aggrecan fragments containing the neoepitope
NVTEGE in discs were detected after 6 months of smoke exposure,
but not after 2 months of exposure (data not shown). This suggests
that long-term exposure is required for ADAMTS-mediated
cleavage of the aggrecan IGD. The presence of the G1 fragment
containing the VDIPEN neoepitope in nonsmokers [Fig. 3(B), lane 4]
suggests occurrence of MMP-mediated proteolysis of aggrecan IGD
with advancing age. However, additional environmental stress
caused by tobacco smoking further increases MMP-mediated
proteolysis of aggrecan [Fig. 3(B), lane 5], contributing to the
decreased disc PG content. It should be noted that metal-
loproteinase expression is not speciﬁcally induced by smoking, but
is up-regulated by a number of other stimuli. However, metal-
loproteinase induction does appear to be important in smoking-
induced aggrecanolysis.
The mechanism by which smoking promotes proteolysis of disc
aggrecan is not known. Expression of MMPs and ADAMTS is greatly
enhanced whereas tissue inhibitor of metalloproteinase (TIMP)
expression is suppressed when disc cells are exposed directly to
tobacco smoke extract (TSE) in vitro35. Direct exposure of disc cells
to toxic, water-soluble by-products of tobacco combustion in vivo is
conceivable as inﬁltration of these smoke constituents could occur
to the more peripheral AF, which is vascularized, or into the NP by
diffusion through the endplate. Aged and degenerated discs,
especially those found in older smokers, could have increased
neovascularization36e38 as a consequence of tissue ﬁssures, whichcould in turn increase exposure of disc cells to the toxic soluble
smoke chemicals in the circulatory system. The presence of tobacco
smoke-induced DNA damage in a variety of tissues (e.g., bone
marrow, bladder, and urethra) far from the primary respiratory
sites of initial contact, support inﬁltration of harmful tobacco
smoke components into distant organs39e41. Thus, direct interac-
tion of disc cells with tobacco smoke chemicals in vivo could cause
up-regulation of MMP and ADAMTS and down-regulation of TIMP
expression, leading to aggrecan degradation observed in smoke-
exposed mice.
Inﬂammatory stress is another key factor causing perturbation
of disc PG homeostasis via increasing matrix catabolism and
decreasing matrix anabolism42e44. Given the existence of
numerous pro-inﬂammatory substances in tobacco smoke45, it is
also possible that smoke-induced cleavage of aggrecan is mediated
through the inﬂammatory pathways. Rats exposed to passive
cigarette smoking for 8 weeks showed a three-fold increase in the
pro-inﬂammatory cytokine IL-1b in their intervertebral disc
tissue12. Polymerase chain reaction (PCR) analysis also revealed
a two-fold increase in IL-1b mRNA in discs of our smoke-exposed
mice (data not shown). Similarly, disc cells exposed to tobacco
smoke extract produce high amounts of the inﬂammatorymediator
prostaglandin F2a, which stimulates MMP expression35. Thus
smoking-induced inﬂammation could up-regulate expression and
activities of the metalloproteinases which act on disc aggrecan to
produce the observed proteolysis. On the other hand, decreased PG
synthesis in discs of smoke-exposed mice could also be due to
cellular senescence (Fig. 4). Senescent chondrocytes have reduced
capacity for PG synthesis46. Cellular senescence can be driven
Fig. 6. A summary of effects of tobacco smoking on spine degeneration. Smoking negatively impacts the major structures of the spine, including vertebral bone, endplate, and
intervertebral disc. Within the intervertebral disc, smoking affects disc cellular function as well as induces matrix aggrecan breakdown. Col, collagen.
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mutagenic compounds in tobacco smoke. Furthermore senescent
cells secrete pro-inﬂammatory cytokines47 which could up-regu-
late catabolism in neighboring cells and extracellular matrix.
Tobacco smoking promotes nicotine-induced vasoconstriction,
increases CO-hemoglobin content48, and accelerates aortic
atherosclerosis and stenosis of the arteries feeding the spine49,50,
all of which lead to the decrease of nutrient and oxygen levels in the
disc. The avascular nature of disc tissue and its relatively poor
nutrition supply make it exceptionally susceptible to the decrease
in nutrient levels that occurs in smokers, causing disc cells to
reduce matrix synthesis to meet their poor nutrient input. Because
the PG synthesis capacity of disc cells also is extremely sensitive to
changes in pH, Urban and coworkers suggested that the fall in
oxygen level in the disc as a result of smoking raises the lactate
level, causing disc pH to drop, which would then suppress PG
synthesis51. Thus, although our study clearly established a direct
causeeeffect relationship between smoking and IDD in mice, it
remains to be investigated whether or not smoking causes IDD
directly by the interaction of its toxic chemicals with disc tissue or
indirectly through the systemic changes, i.e., vasoconstriction,
atherosclerosis, DNA damage, bone marrow alteration.etc., which
in turn adversely affect disc matrix homeostasis.
Unlike all previous studies of IDD which exposed rats or porcine
to passive tobacco smoking, our approach of using the mouse
experimental model of direct smoke inhalation is innovative as it is
a more pertinent model system to study the effects of tobacco
smoking on IDD because it mimic ﬁrst-hand smoking in humans.
Moreover, adapting our experimental smokingmodel tomice offers
a signiﬁcant advance over the formermodel systems in that one can
use gene-targeted mice to dissect the mechanism of smoke-
induced IDD in future studies. For instance, many different MMP
and ADAMT genetic knockout mouse strains exist, and exposing
these strains to tobacco smoke allows for identiﬁcation and delin-
eation of the relative contribution of speciﬁc MMPs and ADAMTSs
to smoking-induced disc aggrecanolysis (Fig. 6).
In summary, mice exposed to direct smoke inhalation to mimic
chronic ﬁrst-hand human smokers exhibit considerable loss ofvertebral bone and disc matrix PG, thus providing clear and
compelling evidence that prolonged exposure to tobacco smoke
can lead to spinal degeneration. Our mouse model of direct smoke-
induced IDD is useful for dissecting and understanding themolecular
and cellular mechanisms underlying the development of smoke-
related IDD. The discovery of smoke-induced proteolysis within
the disc aggrecan IDG at MMP- and ADAMTS-speciﬁc cleavage sites
also provides novel enzyme targets for inhibitors aimed at delaying
the onset or ameliorating the severity of IDD in chronic smokers.
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